首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1608836

先進藥物輸送系統市場：按類型、按應用、按載體類型、按最終用戶、按地區

Advanced Drug Delivery Systems Market, By Type, By Application, By Carrier Type, By End User, By Geography

出版日期: 2024年11月04日 | 出版商:

Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

先進給藥系統市場預計到2024年將達到2,544.4億美元，預計到2031年將達到3,759.4億美元，2024年至2031年的複合年成長率為5.7%。

分析範圍		分析詳情
基準年	2023年	市場規模（2024年）	2544.4億美元
實際資料	2019-2023	預測期	2024-2031
預測期複合年成長率（2024-2031）	5.70%	預計金額（2031年）	3759.4億美元

圖：2024 年先進藥物輸送系統市場佔有率（%），依地區分類

先進的藥物傳輸系統使得新型製劑的開發成為可能，這些製劑可以將藥物特異性靶向體內部位以進行局部或持續治療。奈米技術和其他工程方法促進了智慧遞送載體的創建，例如膠束、樹狀聚合物、脂質體和聚合物奈米顆粒，它們可以保護藥物免於分解並控制其釋放。這種遞送平台透過提高藥物功效和減少不良副作用來幫助改善許多藥物的治療指數。先進的藥物輸送系統能夠跨越生物屏障精確地輸送治療有效載荷，正在徹底改變癌症和其他嚴重疾病的治療。

市場動態：

先進的藥物輸送系統市場是由對標靶和受控藥物輸送的需求不斷成長所推動的。製藥公司增加研發投資以開發創新配方以及癌症等慢性病盛行率的上升正在推動市場成長。然而，高昂的開發成本和監管問題給新參與企業帶來了挑戰。開拓國家尚未開發的潛力提供了市場擴張的機會。此外，先進的給藥技術（例如長效注射劑）的廣泛應用可以為藥物開發商開闢新的途徑。

本研究的主要特點

該報告對全球先進藥物輸送系統市場進行了詳細分析，包括以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR，%）。

它還闡明了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、業績和策略等參數，提供全球先進藥物輸送系統市場主要企業的概況。

主要企業包括 Baxter、3M、Abbott、Datwyler Holding Inc.、Evonik、 Astra Zeneca、Novo Nordisk A/S、Corium Innovations, Inc.、PolyActiva、Teleflex Incorporated、Elixir Medical、B. Braun SE、Nemera 和 Epion Therapeutics Inc. 、 Terumo Corporation和 Flowonix Medical Inc.

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、產品創新、市場擴張和行銷策略做出明智的決策。

本報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員可以透過用於分析全球先進藥物輸送系統市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	254.44 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	5.70%	2031 Value Projection:	375.94 Bn

Advanced drug delivery systems have enabled the development of novel formulations that can specifically target drugs to areas of the body for localized or sustained treatment. Nanotechnology and other engineering approaches have facilitated the creation of intelligent delivery vehicles like micelles, dendrimers, liposomes, and polymeric nanoparticles that can shield drugs from degradation and control their release. Such delivery platforms help improve the therapeutic index of many drugs by increasing their efficacy and reducing unwanted side effects. With their ability to cross biological barriers and precisely deliver therapeutic payloads, advanced drug delivery systems are revolutionizing the treatment of cancer and other serious diseases.

Market Dynamics:

The advanced drug delivery systems market is driven by the growing demand for targeted and controlled drug delivery. Increasing R&D investments by pharmaceutical companies to develop innovative formulations and the rising prevalence of chronic diseases like cancer are fueling market growth. However, high development costs and regulatory issues pose challenges to new entrants. The untapped potential of emerging economies presents an opportunity for market expansion. Additionally, the growing application scope of advanced delivery technologies like long-acting injectables could open new avenues for drug developers.

Key features of the study:

This report provides in-depth analysis of the global advanced drug delivery systems market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global advanced drug delivery systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Baxter, 3M, Abbott, Datwyler Holding Inc., Evonik, Astrazeneca, Novo Nordisk A/S, Corium Innovations, Inc., PolyActiva, Teleflex Incorporated, Elixir Medical, B. Braun SE, Nemera, Epion Therapeutics, Inc., Terumo Corporation, and Flowonix Medical Inc

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global advanced drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global advanced drug delivery systems market

Market Segmentation

Type Insights
- Oral Drug Delivery System
- Injection-Based Drug Delivery System
- Inhalation/Pulmonary Drug Delivery System
- Transdermal Drug Delivery System
- Carrier Based Drug Delivery System
- Others (Transmucosal Drug Delivery System, etc.)
Application Insights
- Cardiovascular Diseases
- Oncology
- Urology
- Ophthalmology
- Inflammatory Diseases
- Others (Infectious Diseases, etc.)
Carrier Type Insights
- Liposomes
- Nanoparticles
- Microspheres
- Monoclonal Antibodies
End User Insights
- Hospitals
- Specialty Clinics
- Others (Research Institutes, etc.)
Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Baxter
- 3M
- Abbott
- Datwyler Holding Inc.
- Evonik
- Astrazeneca
- Novo Nordisk A/S
- Corium Innovations, Inc.
- PolyActiva
- Teleflex Incorporated
- Elixir Medical
- Braun SE
- Nemera
- Epion Therapeutics, Inc.
- Terumo Corporation
- Flowonix Medical Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Advanced Drug Delivery Systems Market, By Type
- Advanced Drug Delivery Systems Market, By Application
- Advanced Drug Delivery Systems Market, By Carrier Type
- Advanced Drug Delivery Systems Market, By End User
- Advanced Drug Delivery Systems Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology

4. Advanced Drug Delivery Systems Market, By Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Injection-Based Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Inhalation/Pulmonary Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Transdermal Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Carrier Based Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Transmucosal Drug Delivery System, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Advanced Drug Delivery Systems Market, By Application, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Urology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Inflammatory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Infectious Diseases, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Advanced Drug Delivery Systems Market, By Carrier Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nanoparticles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Microspheres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Advanced Drug Delivery Systems Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Advanced Drug Delivery Systems Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany

oU.K.

Spain
France
Italy
Russia
Rest of Europe

Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Baxter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
3M
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Datwyler Holding Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evonik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astrazeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novo Nordisk A/S
Corium Innovations, Inc.
PolyActiva
Teleflex Incorporated
Elixir Medical
Braun SE
Nemera
Epion Therapeutics, Inc.
Terumo Corporation
Flowonix Medical Inc